Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, Hairy Cell

Clinical trial condition

Leukemia, Hairy Cell

Explore clinical trials studying Leukemia, Hairy Cell. Study availability and eligibility vary by location and protocol.

170 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Hairy Cell trial results

Completed

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

NCT00003938

Conditions: Adnexal Diseases, Agranulocytosis, Amyloidosis, +147 more
Locations: A.Z. St. Jan Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

Hopital Universitaire Erasme Brussels, Belgium

U.Z. Gasthuisberg Leuven, Belgium

View all 24 locations

View Trial Details

Completed

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

NCT00003805

Conditions: Blast Crisis, Blood Protein Disorders, Body Temperature Changes, +69 more
Locations: Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

Boston Medical Center Boston, Massachusetts, United States

Algemeen Ziekenhuis Middelheim Antwerp, Belgium

Hopital Universitaire Erasme Brussels, Belgium

View all 28 locations

View Trial Details

Completed

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

NCT00666211

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
Locations: Jennie Stuart Medical Center Hopkinsville, Kentucky, United States

Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States

Erlanger Health System Chattanooga, Tennessee, United States

Tennessee Plateau Oncology Crossville, Tennessee, United States

View Trial Details

Completed

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

NCT00004230

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation

NCT00005606

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +35 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004904

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +87 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004232

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +87 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

NCT00237627

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +99 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy

NCT00003757

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Klinik Hirslanden Zurich, Switzerland

View Trial Details

Completed

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

NCT00281801

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +63 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details